<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cfpd</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень физиологии и патологии дыхания</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin Physiology and Pathology of Respiration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1998-5029</issn><publisher><publisher-name>Дальневосточный научный центр физиологии и патологии дыхания</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.36604/1998-5029-2025-96-33-44</article-id><article-id custom-type="elpub" pub-id-type="custom">cfpd-1251</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Уровень аденозинтрифосфата и капсаицин-индуцированные изменения мембранного потенциала митохондрий в мононуклеарах больных хронической обструктивной болезнью легких</article-title><trans-title-group xml:lang="en"><trans-title>Adenosine triphosphate level and capsaicin-induced changes in mitochondrial membrane potential in mononuclear cells of patients with chronic obstructive pulmonary disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сугайло</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Sugaylo</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ивана Юрьевна Сугайло, канд. мед. наук, научный сотрудник</p><p>лаборатория молекулярных и трансляционных исследований</p><p>675000; ул. Калинина, 22; Благовещенск</p></bio><bio xml:lang="en"><p>Ivana Yu. Sugaylo, PhD (Med.), Staff Scientist</p><p>Laboratory of Molecular and Translational Research</p><p>675000; 22 Kalinina Str.; Blagoveshchensk</p></bio><email xlink:type="simple">ivanka_888@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Наумов</surname><given-names>Д. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Naumov</surname><given-names>D. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Денис Евгеньевич Наумов, канд. мед. наук, зав. лабораторией</p><p>лаборатория молекулярных и трансляционных исследований</p><p>675000; ул. Калинина, 22; Благовещенск</p></bio><bio xml:lang="en"><p>Denis E. Naumov, PhD (Med.), Head of Laboratory</p><p>Laboratory of Molecular and Translational Research</p><p>675000; 22 Kalinina Str.; Blagoveshchensk</p></bio><email xlink:type="simple">denn1985@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гассан</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gassan</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Дина Анатольевна Гассан, канд. мед. наук., зав. лабораторией</p><p>лаборатория механизмов вирус-ассоциированных патологий развития</p><p>675000; ул. Калинина, 22; Благовещенск</p></bio><bio xml:lang="en"><p>Dina A. Gassan, PhD (Med.), Head of Laboratory</p><p>Laboratory of Mechanisms of Virus-Associated Developmental Pathologies</p><p>675000; 22 Kalinina Str.; Blagoveshchensk</p></bio><email xlink:type="simple">danishi@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Котова</surname><given-names>О. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Kotova</surname><given-names>O. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Олеся Олеговна Котова, канд. мед. наук., старший научный сотрудник</p><p>лаборатория механизмов вирус-ассоциированных патологий развития</p><p>675000; ул. Калинина, 22; Благовещенск</p></bio><bio xml:lang="en"><p>Olesya O. Kotova, PhD (Med.), Senior Staff Scientist</p><p>Laboratory of Mechanisms of Virus-Associated Developmental Pathologies</p><p>675000; 22 Kalinina Str.; Blagoveshchensk</p></bio><email xlink:type="simple">foxy_voxy_on@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Конев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Konev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андрей Викторович Конев, младший научный сотрудник</p><p>лаборатория механизмов вирус-ассоциированных патологий развития</p><p>675000; ул. Калинина, 22; Благовещенск</p></bio><bio xml:lang="en"><p>Andrey V. Konev, Junior Staff Scientist</p><p>Laboratory of Mechanisms of Virus-Associated Developmental Pathologies</p><p>675000; 22 Kalinina Str.; Blagoveshchensk</p></bio><email xlink:type="simple">andrkonev@vk.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шелудько</surname><given-names>Е. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Sheludko</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елизавета Григорьевна Шелудько, канд. мед. наук, научный сотрудник</p><p>лаборатория молекулярных и трансляционных исследований</p><p>675000; ул. Калинина, 22; Благовещенск</p></bio><bio xml:lang="en"><p>Elizaveta G. Sheludko, PhD (Med.), Staff Scientist</p><p>Laboratory of Molecular and Translational Research</p><p>675000; 22 Kalinina Str.; Blagoveshchensk</p></bio><email xlink:type="simple">liza.sheludko@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное научное учреждение «Дальневосточный научный центр физиологии и патологии дыхания»</institution></aff><aff xml:lang="en"><institution>Far Eastern Scientific Center of Physiology and Pathology of Respiration</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>24</day><month>06</month><year>2025</year></pub-date><volume>0</volume><issue>96</issue><fpage>33</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сугайло И.Ю., Наумов Д.Е., Гассан Д.А., Котова О.О., Конев А.В., Шелудько Е.Г., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Сугайло И.Ю., Наумов Д.Е., Гассан Д.А., Котова О.О., Конев А.В., Шелудько Е.Г.</copyright-holder><copyright-holder xml:lang="en">Sugaylo I.Y., Naumov D.E., Gassan D.A., Kotova O.O., Konev A.V., Sheludko E.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cfpd.elpub.ru/jour/article/view/1251">https://cfpd.elpub.ru/jour/article/view/1251</self-uri><abstract><sec><title>   Введение</title><p>   Введение. Энергетическое обеспечение клеток – ключевой аспект их функционирования, осуществляемый митохондриями. Несмотря на сообщения о наличии энергетического дефицита при ХОБЛ, ранее мы выявили увеличение мембранного потенциала митохондрий (ΔΨm) в лейкоцитах больных лиц. В то же время при ХОБЛ отмечалась повышенная экспрессия каналов с транзиторным рецепторным потенциалом TRPV1, что вызывает вопросы о возможной роли этих рецепторов в регуляции митохондриальных функций.</p></sec><sec><title>   Цель</title><p>   Цель. Оценить уровень ΔΨm и аденозинтрифосфата (АТФ) в мононуклеарах периферической крови больных ХОБЛ, а также уточнить эффект агониста TRPV1 – капсаицина – на ΔΨm.</p></sec><sec><title>   Материалы и методы</title><p>   Материалы и методы. В исследование было включено 42 больных ХОБЛ различной степени тяжести, 11 лиц контрольной группы без признаков бронхиальной обструкции. Всем испытуемым проведены спирометрия и бодиплетизмография для оценки вентиляционной функции легких. Количество АТФ измеряли люминометрическим методом на планшетном анализаторе, после чего рассчитывали среднее содержание АТФ на одну клетку. ΔΨm определяли методом проточной цитометрии с использованием ратиометрического катионного карбонилцианинового красителя JC-1. Вычисляли динамику ΔΨm в ответ на активацию TRPV1 капсаицином, результаты выражали в % к значению ΔΨm в клетках, которым стимуляцию не проводили.</p></sec><sec><title>   Результаты</title><p>   Результаты. Выявлено, что содержание АТФ в мононуклеарах периферической крови больных ХОБЛ было выше, чем у лиц контрольной группы (0,96 (0,36; 1,79) фмоль/кл. против 0,14 (0,11; 0,21) фмоль/кл., p = 0,001). Капсаицин вызывал значимые изменения ΔΨm в мононуклеарах больных ХОБЛ: 33,1 (-19,0; 86,0)% для лимфоцитов и 48,2 (0,0; 126,7) % для моноцитов (p = 0,001). Тем не менее, ΔΨm не имел значимых различий между больными ХОБЛ и лицами контрольной группы ни исходно, ни на фоне действия капсаицина. При более высоких значениях объема форсированного выдоха за 1 секунду у больных ХОБЛ ΔΨm был выше как в лимфоцитах (0,69 (0,64; 0,86) против 0,51 (0,35; 0,61), р = 0,004), так и в моноцитах (0,28 (0,21; 0,37) против 0,18 (0,13; 0,29), р =0,015).</p></sec><sec><title>   Заключение</title><p>   Заключение. Мы не выявили признаков энергетического дефицита в мононуклеарах больных ХОБЛ, однако у пациентов с тяжелыми и крайне тяжелыми вентиляционными нарушениями может происходить некоторое снижение ΔΨm, не влияющее на выработку АТФ. Повышенная продукция АТФ при ХОБЛ может быть опосредована увеличенной экспрессией TRPV1 и может играть патологическую роль за счет активации пуринергического сигналинга.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>   Introduction</title><p>   Introduction. Cellular energy supply is a key aspect of their functioning, mediated by mitochondria. Despite reports of energy deficiency in COPD, we previously found an increase in mitochondrial membrane potential (ΔΨm) in the leukocytes of affected individuals. At the same time, increased expression of transient receptor potential channels TRPV1 was observed in COPD, raising questions about their potential role in regulating mitochondrial functions.</p></sec><sec><title>   Aim</title><p>   Aim. To assess ΔΨm and adenosine triphosphate (ATP) levels in peripheral blood mononuclear cells of COPD patients and to clarify the effect of the TRPV1 agonist capsaicin on ΔΨm.</p></sec><sec><title>   Materials and methods</title><p>   Materials and methods. The study included 42 COPD patients of varying severity and 11 control subjects without signs of bronchial obstruction. All participants underwent spirometry and body plethysmography to assess lung function. The amount of ATP was measured by the luminometric method on a plate analyzer, with mean ATP content per cell calculated. ΔΨm was determined by flow cytometry using the ratiometric cationic carbonylcyanine dye JC-1. The dynamics of ΔΨm in response to TRPV1 activation by capsaicin were assessed and the results were expressed as a percentage of ΔΨm in unstimulated cells.</p></sec><sec><title>   Results</title><p>   Results. It was found that the ATP content in the peripheral blood mononuclear cells of COPD patients was higher than in the control group (0.96 (0.36; 1.79) fmol/cell vs. 0.14 (0.11; 0.21) fmol/cell, p = 0.001). Capsaicin caused significant changes in ΔΨm in the mononuclear cells of COPD patients: 33.1 (-19.0; 86.0)% for lymphocytes and 48.2 (0.0; 126.7) % for monocytes (p = 0.001). However, ΔΨm did not differ significantly between COPD patients and the control group either at baseline or under capsaicin stimulation. In COPD patients with higher FEV1 values, ΔΨm was elevated in both lymphocytes (0.69 (0.64; 0.86) vs. 0.51 (0.35; 0.61), p = 0.004) and monocytes (0.28 (0.21; 0.37) vs. 0.18 (0.13; 0.29), p = 0.015).</p></sec><sec><title>   Conclusion</title><p>   Conclusion. We found no evidence of energy deficiency in mononuclear cells from COPD patients, however, in patients with severe and very severe ventilatory impairment, some decrease in ΔΨm may occur without affecting ATP production. Increased ATP production in COPD may be mediated by increased TRPV1 expression and could play a pathological role by activating purinergic signaling.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>мембранный потенциал митохондрий</kwd><kwd>митохондрии</kwd><kwd>АТФ</kwd><kwd>TRPV1</kwd><kwd>хроническая обструктивная болезнь легких</kwd><kwd>активные формы кислорода</kwd><kwd>мононуклеары</kwd></kwd-group><kwd-group xml:lang="en"><kwd>mitochondrial membrane potential</kwd><kwd>mitochondria</kwd><kwd>ATP</kwd><kwd>TRPV1</kwd><kwd>chronic obstructive pulmonary disease</kwd><kwd>reactive oxygen species</kwd><kwd>PBMC</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено в рамках программы фундаментальных исследований Министерства науки и высшего образования РФ (FGWF-2025-0009)</funding-statement><funding-statement xml:lang="en">This study was supported by the Ministry of Science and Higher Education of the Russian Federation under the Program for Basic Research (FGWF-2025-0009)</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Prevention, Diagnosis and Management of Chronic Obstructive Pulmonary Disease. 2025. URL: http://www.goldcopd.org</mixed-citation><mixed-citation xml:lang="en">Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for Prevention, Diagnosis and Management of Chronic Obstructive Pulmonary Disease. 2025. Available at: http://www.goldcopd.org</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Boers E., Barrett M., Vuong V., Benjafield A., Su J., Kaye L., Tellez D., Nunez C., Malhotra A. An estimate of the global COPD prevalence in 2050: Disparities by income and gender // Eur. Respir. J. 2022. Vol. 60, Suppl. 66. Article number: 4608. doi: 10.1183/13993003.congress-2022.4608</mixed-citation><mixed-citation xml:lang="en">Boers E., Barrett M., Vuong V., Benjafield A., Su J., Kaye L., Tellez D., Nunez C., Malhotra A. An estimate of the global COPD prevalence in 2050: disparities by income and gender. Eur. Respir. J. 2022; 60(66):4608. doi: 10.1183/13993003.congress-2022.4608</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rey-Brandariz J., Pérez-Ríos M., Ahluwalia J.S., Beheshtian K., Fernández-Villar A., Represas-Represas C., Piñeiro M., Alfageme I., Ancochea J., Soriano J.B., Casanova C., Cosío B.G., García-Río F., Miravitlles M., de Lucas P., Rodríguez González-Moro J.M., Soler-Cataluña J.J., Ruano-Ravina A. Tobacco patterns and risk of chronic obstructive pulmonary disease: results from a cross-sectional study // Arch. Bronconeumol. 2023. Vol. 59, Iss. 11. P. 717–724. doi: 10.1016/j.arbres.2023.07.009</mixed-citation><mixed-citation xml:lang="en">Rey-Brandariz J., Pérez-Ríos M., Ahluwalia J.S., Beheshtian K., Fernández-Villar A., Represas-Represas C., Piñeiro M., Alfageme I., Ancochea J., Soriano J.B., Casanova C., Cosío B.G., García-Río F., Miravitlles M., de Lucas P., Rodríguez González-Moro J.M., Soler-Cataluña J.J., Ruano-Ravina A. Tobacco patterns and risk of chronic obstructive pulmonary disease: results from a cross-sectional study. Arch. Bronconeumol. 2023; 59(11):717–724, doi: 10.1016/j.arbres.2023.07.009</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zong Y., Li H., Liao P., Chen L., Pan Y., Zheng Y., Zhang C., Liu D., Zheng M., Gao J. Mitochondrial dysfunction: mechanisms and advances in therapy // Signal Transduct. Target Ther. 2024. Vol. 9, Suppl. 1. Article number: 124. doi: 10.1038/s41392-024-01839-8</mixed-citation><mixed-citation xml:lang="en">Zong Y., Li H., Liao P., Chen L., Pan Y., Zheng Y., Zhang C., Liu D., Zheng M., Gao J. Mitochondrial dysfunction: mechanisms and advances in therapy. Signal Transduct. Target Ther. 2024; 9(1):124. doi: 10.1038/s41392-024-01839-8</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Зорова Л.Д., Попков В.А., Плотников Е.Ю., Силачев Д.Н., Певзнер И.Б., Янкаускас С.С., Зоров С.Д., Бабенко В.А., Зоров Д.Б. Функциональная значимость митохондриального мембранного потенциала // Биологические мембраны. 2017. Т. 34, № 6. С. 93–100. doi: 10.7868/S0233475517060020</mixed-citation><mixed-citation xml:lang="en">Zorova L.D., Popkov V.A., Plotnikov E.J., Silachev D.N., Pevzner I.B., Yankauskas S.S., Zorov S.D., Babenko V.A., Zorov D.B. [Role of mitochondrial membrane potential]. Biologicheskie membrany 2017; 34(6):93–100 (in Russian). doi: 10.7868/S0233475517060020</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rajasekaran N.S., Connell P., Christians E.S., Yan L.J., Taylor R.P., Orosz A., Zhang X.Q., Stevenson T.J., Peshock R.M., Leopold J.A., Barry W.H., Loscalzo J., Odelberg S.J., Benjamin I.J. Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice // Cell. 2007. Vol. 130, Iss. 3. P. 427–439. doi: 10.1016/j.cell.2007.06.044</mixed-citation><mixed-citation xml:lang="en">Rajasekaran N.S., Connell P., Christians E.S., Yan L.J., Taylor R.P., Orosz A., Zhang X.Q., Stevenson T.J., Peshock R.M., Leopold J.A., Barry W.H., Loscalzo J., Odelberg S.J., Benjamin I.J. Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell 2007; 130(3):427–439. doi: 10.1016/j.cell.2007.06.044</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Li C.L., Liu J.F., Liu S.F. Mitochondrial dysfunction in chronic obstructive pulmonary disease: unraveling the molecular nexus // Biomedicines. 2024. Vol. 12, Suppl. 4. Article numberт: 814. doi: 10.3390/biomedicines12040814</mixed-citation><mixed-citation xml:lang="en">Li C.L., Liu J.F., Liu S.F. Mitochondrial dysfunction in chronic obstructive pulmonary disease: unraveling the molecular nexus. Biomedicines 2024; 12(4):814. doi: 10.3390/biomedicines12040814</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Puente-Maestu L., Pérez-Parra J., Godoy R., Moreno N., Tejedor A., González-Aragoneses F., Bravo J.L., Alvarez F.V., Camaño S., Agustí A. Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients // Eur. Respir. J. 2009. Vol. 33, Iss. 5. P. 1045–1052. doi: 10.1183/09031936.00112408</mixed-citation><mixed-citation xml:lang="en">Puente-Maestu L., Pérez-Parra J., Godoy R., Moreno N., Tejedor A., González-Aragoneses F., Bravo J.L., Alvarez F.V., Camaño S., Agustí A. Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur. Respir. J. 2009; 33(5):1045–1052. doi: 10.1183/09031936.00112408</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Wiegman C.H., Michaeloudes C., Haji G., Narang P., Clarke C.J., Russell K.E., Bao W., Pavlidis S., Barnes P.J., Kanerva J., Bittner A., Rao N., Murphy M.P., Kirkham P.A., Chung K.F., Adcock I.M. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease // J. Allergy Clin. Immunol. 2015. Vol.136, Iss.3. P.769–780. doi: 10.1016/j.jaci.2015.01.046</mixed-citation><mixed-citation xml:lang="en">Wiegman C.H., Michaeloudes C., Haji G., Narang P., Clarke C.J., Russell K.E., Bao W., Pavlidis S., Barnes P.J., Kanerva J., Bittner A., Rao N., Murphy M.P., Kirkham P.A., Chung K.F., Adcock I.M., COPDMAP. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2015; 136(3):769–780. doi: 10.1016/j.jaci.2015.01.046</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Agarwal A.R., Kadam S., Brahme A., Agrawal M., Apte K., Narke G., Kekan K., Madas S., Salvi S. Systemic immuno-metabolic alterations in chronic obstructive pulmonary disease (COPD) // Respir. Res. 2019. Vol. 20, Iss. 1. Article number: 171. doi: 10.1186/s12931-019-1139-2</mixed-citation><mixed-citation xml:lang="en">Agarwal A.R., Kadam S., Brahme A., Agrawal M., Apte K., Narke G., Kekan K., Madas S., Salvi S. Systemic Immuno-metabolic alterations in chronic obstructive pulmonary disease (COPD). Respir. Res. 2019; 20(1):171. doi: 10.1186/s12931-019-1139-2</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Бельских Э.С., Урясьев О.М., Звягина В.И., Фалетрова С.В. Развитие вторичной митохондриальной дисфункции мононуклеарных лейкоцитов крови у больных хронической обструктивной болезнью легких и хроническим бронхитом // Казанский медицинский журнал. 2018. Т. 99, № 5. С. 741–747. doi: 10.17816/KMJ2018-741</mixed-citation><mixed-citation xml:lang="en">Bel’skikh E.S., Uryas’ev O.M., Zvyagina V.I., Faletrova S.V [Development of secondary mitochondrial dysfunction of mononuclear blood leukocytes in patients with chronic obstructive pulmonary disease and chronic bronchitis]. Kazan Medical Journal 2018; 99(5):741–747 (in Russian). doi: 10.17816/KMJ2018-741</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Сугайло И.Ю., Гассан Д.А., Наумов Д.Е., Котова О.О., Горчакова Я.Г., Шелудько Е.Г. Состояние мембранного потенциала митохондрий в лейкоцитах периферической крови больных хронической обструктивной болезнью легких // Бюллетень физиологии и патологии дыхания. 2023. Вып. 89. С. 25–35. doi: 10.36604/1998-5029-2023-89-25-35</mixed-citation><mixed-citation xml:lang="en">Sugaylo I.Yu., Gassan D.A., Naumov D.E., Kotova O.O., Gorchakova Y.G., Sheludko E.G. [The state of mitochondrial membrane potential in peripheral blood leukocytes of patients with chronic obstructive pulmonary disease]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2023; 89:25–35 (in Russian). doi: 10.36604/1998-5029-2023-89-25-35</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ederlé C., Charles A.L., Khayath N., Poirot A., Meyer A., Clere-Jehl R., Andres E., De Blay F., Geny B. Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation // J. Clin. Med. 2019. Vol. 8, Iss. 10. Article number: 1613. doi: 10.3390/jcm8101613</mixed-citation><mixed-citation xml:lang="en">Ederlé C., Charles A.L., Khayath N., Poirot A., Meyer A., Clere-Jehl R., Andres E., De Blay F., Geny B. Mitochondrial function in peripheral blood mononuclear cells (PBMC) is enhanced, together with increased reactive oxygen species, in severe asthmatic patients in exacerbation. J. Clin. Med. 2019; 8(10):1613. doi: 10.3390/jcm8101613</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Наумов Д.Е., Сугайло И.Ю., Котова О.О., Гассан Д.А., Горчакова Я.Г., Шелудько Е.Г. Экспрессия каналов с транзиторным рецепторным потенциалом (TRP) на лейкоцитах периферической крови больных хронической обструктивной болезнью легких // Сибирский журнал клинической и экспериментальной медицины. 2023. Т. 38, № 4. С. 125–132. doi: 10.29001/2073-8552-2023-659</mixed-citation><mixed-citation xml:lang="en">Naumov D.E., Sugaylo I.Yu., Kotova O.O., Gassan D.A., Gorchakova Y.G., Sheludko E.G. [Expression of transient receptor potential channels on peripheral blood leukocytes of patients with chronic obstructive pulmonary disease]. Siberian Journal of Clinical and Experimental Medicine 2023; 38(4):125–132 (in Russian). doi: 10.29001/2073-8552-2023-659</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ogawa N., Kurokawa T., Mori Y. Sensing of redox status by TRP channels // Cell Calcium. 2016. Vol. 60, Iss. 2. P. 115–122. doi: 10.1016/j.ceca.2016.02.009</mixed-citation><mixed-citation xml:lang="en">Ogawa N., Kurokawa T., Mori Y. Sensing of redox status by TRP channels. Cell Calcium 2016; 60(2):115–122. doi: 10.1016/j.ceca.2016.02.009</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Grace M.S., Baxter M., Dubuis E., Birrell M.A., Belvisi M.G. Transient receptor potential (TRP) channels in the airway: role in airway disease // Br. J. Pharmacol. 2014. Vol. 171. Р. 2593–2607. doi: 10.1111/bph.12538</mixed-citation><mixed-citation xml:lang="en">Grace M.S., Baxter M., Dubuis E., Birrell M.A., Belvisi M.G. Transient receptor potential (TRP) channels in the airway: role in airway disease. Br. J. Pharmacol. 2014; 171:2593–2607. doi: 10.1111/bph.12538</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Lang H., Li Q., Yu H., Li P., Lu Z., Xiong S., Yang T., Zhao Y., Huang X., Gao P., Zhang H., Shang Q., Liu D., Zhu Z. Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function // Br. J. Pharmacol. 2015. Vol. 172, Iss. 23. P. 5548–5558. doi: 10.1111/bph.12987</mixed-citation><mixed-citation xml:lang="en">Lang H., Li Q., Yu H., Li P., Lu Z., Xiong S., Yang T., Zhao Y., Huang X., Gao P., Zhang H., Shang Q., Liu D., Zhu Z. Activation of TRPV1 attenuates high salt-induced cardiac hypertrophy through improvement of mitochondrial function. Br. J. Pharmacol. 2015; 172(23):5548–5558. doi: 10.1111/bph.12987</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Otto M., Bucher C., Liu W., Müller M., Schmidt T., Kardell M., Driessen M.N., Rossaint J., Gross E.R., Wagner N.M. 12(S)-HETE mediates diabetes-induced endothelial dysfunction by activating intracellular endothelial cell TRPV1 // J. Clin. Investig. 2020. Vol. 130, Iss. 9. P. 4999–5010. doi: 10.1172/JCI136621</mixed-citation><mixed-citation xml:lang="en">Otto M., Bucher C., Liu W., Müller M., Schmidt T., Kardell M., Driessen M.N., Rossaint J., Gross E.R., Wagner N.M. 12(S)-HETE mediates diabetes-induced endothelial dysfunction by activating intracellular endothelial cell TRPV1. J. Clin. Investig. 2020; 130(9):4999–5010. doi: 10.1172/JCI136621</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Perelman A., Wachtel C., Cohen M., Haupt S., Shapiro H., Tzur A. JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry // Cell Death Dis. 2012. Vol. 3, Iss. 11. Article number: e430. doi: 10.1038/cddis.2012.171</mixed-citation><mixed-citation xml:lang="en">Perelman A., Wachtel C., Cohen M., Haupt S., Shapiro H., Tzur A. JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis. 2012; 3(11):e430. doi: 10.1038/cddis.2012.171</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Perry S.W., Norman J.P., Barbieri J., Brown E.B., Gelbard H.A. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide // Biotechniques. 2011. Vol.50, Iss.2. P.98–115. doi: 10.2144/000113610</mixed-citation><mixed-citation xml:lang="en">Perry S.W., Norman J.P., Barbieri J., Brown E.B., Gelbard H.A. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. Biotechniques 2011; 50(2):98–115. doi: 10.2144/000113610</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Weinberg S.E., Sena L.A., Chandel N.S. Mitochondria in the regulation of innate and adaptive immunity // Immunity. 2015. Vol. 42, Iss. 3. P. 406–417. doi: 10.1016/j.immuni.2015.02.002</mixed-citation><mixed-citation xml:lang="en">Weinberg S.E., Sena L.A., Chandel N.S. Mitochondria in the regulation of innate and adaptive immunity. Immunity 2015; 42(3):406–417. doi: 10.1016/j.immuni.2015.02.002</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sena L.A., Li S., Jairaman A., Prakriya M., Ezponda T., Hildeman D.A., Wang C.R., Schumacker P.T., Licht J.D., Perlman H., Bryce P.J., Chandel N.S. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling // Immunity. 2013. Vol. 38, Iss. 2. P. 225–236. doi: 10.1016/j.immuni.2012.10.020</mixed-citation><mixed-citation xml:lang="en">Sena L.A., Li S., Jairaman A., Prakriya M., Ezponda T., Hildeman D.A., Wang C.R., Schumacker P.T., Licht J.D., Perlman H., Bryce P.J., Chandel N.S. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity 2013; 38(2):225–236. doi: 10.1016/j.immuni.2012.10.020</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kelley N., Jeltema D., Duan Y., He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation // Int. J. Mol. Sci. 2019. Vol. 20, Iss. 13. Article number: 3328. doi: 10.3390/ijms20133328</mixed-citation><mixed-citation xml:lang="en">Kelley N., Jeltema D., Duan Y., He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int. J. Mol. Sci. 2019; 20(13):3328. doi: 10.3390/ijms20133328</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Bao Y., Ledderose C., Seier T., Graf A.F., Brix B., Chong E., Junger W.G. Mitochondria regulate neutrophil activation by generating ATP for autocrine purinergic signaling // J. Biol. Chem. 2014. Vol. 289, Iss. 39. P. 26794–26803. doi: 10.1074/jbc.M114.572495</mixed-citation><mixed-citation xml:lang="en">Bao Y., Ledderose C., Seier T., Graf A.F., Brix B., Chong E., Junger W.G. Mitochondria regulate neutrophil activation by generating ATP for autocrine purinergic signaling. J. Biol. Chem. 2014; 289(39):26794–26803. doi: 10.1074/jbc.M114.572495</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lommatzsch M., Cicko S., Müller T., Lucattelli M., Bratke K., Stoll P., Grimm M., Dürk T., Zissel G., Ferrari D., Di Virgilio F., Sorichter S., Lunga-rella G., Virchow J.C., Idzko M. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease // Am. J. Respir. Crit. Care Med. 2010. Vol. 181, Iss. 9. P. 928–934. doi: 10.1164/rccm.200910-1506OC</mixed-citation><mixed-citation xml:lang="en">Lommatzsch M., Cicko S., Müller T., Lucattelli M., Bratke K., Stoll P., Grimm M., Dürk T., Zissel G., Ferrari D., Di Virgilio F., Sorichter S., Lunga-rella G., Virchow J.C., Idzko M. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010; 181(9):928–934. doi: 10.1164/rccm.200910-1506OC</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Cicko S., Lucattelli M., Müller T., Lommatzsch M., De Cunto G., Cardini S., Sundas W., Grimm M., Zeiser R., Dürk T., Zissel G., Boeynaems J.M., Sorichter S., Ferrari D., Di Virgilio F., Virchow J.C., Lungarella G., Idzko M. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema // J. Immunol. 2010. Vol. 185, Iss. 1. P. 688–697. doi: 10.4049/jimmunol.0904042</mixed-citation><mixed-citation xml:lang="en">Cicko S., Lucattelli M., Müller T., Lommatzsch M., De Cunto G., Cardini S., Sundas W., Grimm M., Zeiser R., Dürk T., Zissel G., Boeynaems J.M., Sorichter S., Ferrari D., Di Virgilio F., Virchow J.C., Lungarella G., Idzko M. Purinergic receptor inhibition prevents the development of smoke-induced lung injury and emphysema. J. Immunol. 2010; 185(1):688–697. doi: 10.4049/jimmunol.0904042</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mortaz E., Braber S., Nazary M., Givi M.E., Nijkamp F.P., Folkerts G. ATP in the pathogenesis of lung emphysema // Eur. J. Pharmacol. 2009. Vol. 619, Iss. 1-3. P. 92–96. doi: 10.1016/j.ejphar.2009.07.022</mixed-citation><mixed-citation xml:lang="en">Mortaz E., Braber S., Nazary M., Givi M.E., Nijkamp F.P., Folkerts G. ATP in the pathogenesis of lung emphysema. Eur. J. Pharmacol. 2009; 619(1-3):92–96. doi: 10.1016/j.ejphar.2009.07.022</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Denton R.M. Regulation of mitochondrial dehydrogenases by calcium ions // Biochim. Biophys. Acta. 2009. Vol. 1787, Iss. 11. P. 1309–1316. doi: 10.1016/j.bbabio.2009.01.005</mixed-citation><mixed-citation xml:lang="en">Denton R.M. Regulation of mitochondrial dehydrogenases by calcium ions. Biochim. Biophys. Acta. 2009; 1787(11):1309–1316. doi: 10.1016/j.bbabio.2009.01.005</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Ponnalagu D., Singh H. Insights into the role of mitochondrial ion channels in inflammatory response // Front. Physiol. 2020. Vol. 11. Article number: 258. doi: 10.3389/fphys.2020.00258</mixed-citation><mixed-citation xml:lang="en">Ponnalagu D., Singh H. Insights into the role of mitochondrial ion channels in inflammatory response. Front. Physiol. 2020; 11:258. doi: 10.3389/fphys.2020.00258</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kong F., You H., Zheng K., Tang R., Zheng C. The crosstalk between pattern-recognition receptor signaling and calcium signaling // Int. J. Biol. Macromol. 2021. Vol. 192. P. 745–756. doi: 10.1016/j.ijbiomac.2021.10.014</mixed-citation><mixed-citation xml:lang="en">Kong F., You H., Zheng K., Tang R., Zheng C. The crosstalk between pattern-recognition receptor signaling and calcium signaling. Int. J. Biol. Macromol. 2021; 192:745–756. doi: 10.1016/j.ijbiomac.2021.10.014</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Bhave G., Hu H.J., Glauner K.S., Zhu W., Wang H., Brasier D.J., Oxford G.S., Gereau R.W.4&lt;sup&gt;th&lt;/sup&gt;. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1) // Proc. Natl. Acad. Sci. USA. 2003. Vol. 100, Iss. 21. P. 12480–12485. doi: 10.1073/pnas.2032100100</mixed-citation><mixed-citation xml:lang="en">Bhave G., Hu H.J., Glauner K.S., Zhu W., Wang H., Brasier D.J., Oxford G.S., Gereau R.W. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Proc. Natl. Acad. Sci. USA. 2003; 100(21):12480–12485. doi: 10.1073/pnas.2032100100</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Kao C.C., Hsu J.W., Bandi V., Hanania N.A., Kheradmand F., Jahoor F. Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease // J. Appl. Physiol. (1985). 2012. Vol. 112, Iss. 1. P. 42–47. doi: 10.1152/japplphysiol.00599.2011</mixed-citation><mixed-citation xml:lang="en">Kao C.C., Hsu J.W., Bandi V., Hanania N.A., Kheradmand F., Jahoor F. Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease. J. Appl. Physiol. (1985). 2012; 112(1):42–47. doi: 10.1152/japplphysiol.00599.2011</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ferreira B.L., Sousa M.B., Leite G.G.F., Brunialti M.K.C., Nishiduka E.S., Tashima A.K., van der Poll T., Salomão R. Glucose metabolism is upregulated in the mononuclear cell proteome during sepsis and supports endotoxin-tolerant cell function // Front. Immunol. 2022. Vol. 13. Article number: 1051514. doi: 10.3389/fimmu.2022.1051514</mixed-citation><mixed-citation xml:lang="en">Ferreira B.L., Sousa M.B., Leite G.G.F., Brunialti M.K.C., Nishiduka E.S., Tashima A.K., van der Poll T., Salomão R. Glucose metabolism is upregulated in the mononuclear cell proteome during sepsis and supports endotoxin-tolerant cell function. Front. Immunol. 2022; 13:1051514. doi: 10.3389/fimmu.2022.1051514</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
